未登录

X

Xiangde Zhao

Zhejiang University

H指数:12

被引数:531

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venous thromboembolism after hip arthroscopy: a systematic review of incidence, risk factors, and international guidelines

髋关节镜术后静脉血栓栓塞症：发病情况、危险因素及国际指南的系统评价

FRONTIERS IN SURGERY

IF1.8

2025-10-140

OAAI

Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice (vol 10, 80, 2024)

CELL DEATH DISCOVERY

IF7

2024-07-090

OAAI

Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice

Mulberrostide A抑制Mitf相关的自噬改善破骨细胞生成并对抗OVX诱导的小鼠骨质疏松症

CELL DEATH DISCOVERY

IF7

2024-02-151

OAAI

Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway

JOURNAL OF BONE ONCOLOGY

IF3.5

2022-08-015

OAAI

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation

NATURE COMMUNICATIONS

IF15.7

2022-01-1021

OAAI

The SFRP1 Inhibitor WAY-316606 Attenuates Osteoclastogenesis Through Dual Modulation of Canonical Wnt Signaling

JOURNAL OF BONE AND MINERAL RESEARCH

IF5.9

2021-09-078

OA

Oxidative Stress-Induced Hypermethylation of KLF5 Promoter Mediated by DNMT3B Impairs Osteogenesis by Diminishing the Interaction with β-Catenin

ANTIOXIDANTS & REDOX SIGNALING

IF6.1

2021-07-0123

PRE

The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice (vol 34, pg 911, 2019)

JOURNAL OF BONE AND MINERAL RESEARCH

IF5.9

2020-06-172

OAAI

The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling

Nrf2激活RTA-408通过抑制STING依赖的nf-κb信号减弱破骨细胞生成

IF11.9

2020-01-01116

OAAI

The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice

CELL COMMUNICATION AND SIGNALING

IF8.9

2019-10-2620

OAAI

The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice

JOURNAL OF BONE AND MINERAL RESEARCH

IF5.9

2019-01-0724

OAAI

Activating -catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK

IF4.2

2018-12-0720

OAAI

MicroRNA-543 promotes ovariectomy-induced osteoporosis through inhibition of AKT/p38 MAPK signaling pathway by targeting YAF2

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2018-12-028

PREAI